NanoViricitudes, Inc. (OTCMKTS:NNVC) Looks at Higher Possible Peaks
Although the daily climbing percentages are quite tame for NanoViricitudes, Inc. (OTCMKTS:NNVC), the company is at the top of a clear rising trend, one that developed in the past weeks. On Friday, NNVC added around 5% to trade at 89 cents, and awaits the new market opening with bated breath, to check how well the trend will hold.
NNVC has been rising since its latest promotional email on June 3rd, and along with that came a series of press releases on the company’s agreements to work with European health agencies. Also, the ticker may be boosted by an upcoming FDA verdict on the release of a drug against dengue fever, a rare tropical disease. While this drug does not promise mass sales, it is a way to inform investors that the ticker belongs to a solid, working company.
Valued at $144 million, the company relies on the following financial background:
- $15.4 million cash
- $17.8 million total assets
- $7.7 million total liabilities
- $3.6 million quarterly net loss
- $36 million loss for 96 months
The company is still on shaky ground when it comes to revenues, and like many drug developers races against time. Also, the ticker is at risk for losing investor sentiment, once the thrill of promises wears out.
Currently, NNVC is still in its habitual range from the past year and a half, hovering between 30 cents and a dollar. The latest trend may result in revisiting the high levels of past years. Still, NNVC is capable of making quite deep cuts. Biopharmaceutical companies behave this way, especially when there are not enough upcoming drug trials or releases to boost the trend.
NNVC is coming to life in a strong series for drug and therapy developers, with several tickers trading in high volumes. Several of the companies are more solid than the usual penny stock, and attract active interest.
The ticker was promoted by a series of professional pump companies, which took up the selection for free, to boost their records with a company more solid and “flushed with cash” in comparison to other small cap businesses. The latest promoter was StockRoach.com, which has since moved on to one of the loudest promotions, Tungsten Corp. (OTCMKTS:TUNG). Unlike NNVC, TUNG is not faring well on the promotional attention.
The StockRoach.com pumper also participated in the unfortunate Tranzbyte, Corp. (OTCMKTS:ERBB) promotion, a recently changed ticker that did not fare well under the new identity. This further shows that NNVC is a breath of fresh air, and a record-boosting selection amid a series of unfortunate pumps.